Victory Capital Management’s TELA Bio TELA Stock Holding History

Victory Capital Management’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,422	Closed	-$12K	–	3215
2020 Q1	$12K	Buy	+1,422	New	+$19.2K	﹤0.01%	3262

Other funds holding TELA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Victory Capital Management's TELA Position: Q2 2020 in Review

Victory Capital Management sold out of TELA Bio (TELA) in Q2 2020, closing a stake of 1,422 shares — an estimated $12K sold.

Victory Capital Management first reported a position in TELA in Q1 2020 and held it in 1 quarter. The position peaked at $12K in Q1 2020. 49 funds tracked by Wall St. Rank hold TELA as of Q2 2020.

Victory Capital Management reported no remaining TELA Bio position as of Q2 2020 after selling out during the quarter.
Victory Capital Management sold 1,422 TELA Bio shares in Q2 2020, an estimated $12K.
Victory Capital Management first reported a position in TELA Bio in Q1 2020 and held it in 1 quarter.
Victory Capital Management's TELA Bio position peaked at $12K in Q1 2020.
49 funds tracked by Wall St. Rank held TELA Bio as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.